Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022)

Administered by Department of Veterans' Affairs

Legislation au F2022L01130 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

CONJUNCTIVITIS

(REASONABLE HYPOTHESIS) (NO. 90 OF 2022)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986 (the VEA), Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022).

3.             This Instrument amends Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 76 of 2020) (Federal Register of Legislation No. F2020L01395) by:

  • inserting a new factor in subsection 9(5A) concerning 'having a sensitising exposure to an allergen'; and
  • inserting a definition of 'sensitising exposure to an allergen' in Schedule 1  Dictionary.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to having a sensitising exposure to an allergen  as a factor in conjunctivitis in the Government Notices Gazette of 10 May 2022, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to 'having a sensitising exposure to an allergen' as a factor in conjunctivitis as advertised in the Government Notices Gazette of 10 May 2022.

References

8.             A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 90 of 2022

Kind of Injury, Disease or Death: Conjunctivitis

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have conjunctivitis;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes having a sensitising exposure to an allergen  as a new factor which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting conjunctivitis with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 76 of 2022; and
  • reflects developments in the available sound medical-scientific evidence concerning conjunctivitis which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning Conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022) amends the Statement of Principles concerning Conjunctivitis (Reasonable Hypothesis) (No. 76 of 2020) under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This amendment was enacted to address the inclusion of 'having a sensitising exposure to an allergen' as a factor for conjunctivitis, a condition that may be linked to the service of veterans and service personnel. The Repatriation Medical Authority, under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986, introduced this instrument to enhance the assessment and determination of compensation claims by incorporating the latest medical-scientific evidence. The policy objective of this amendment is to ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby facilitating better outcomes for veterans and their dependents. The Authority undertook an investigation and public consultation prior to determining this amendment, inviting submissions from relevant stakeholders. The amendment reflects the evolving understanding of the medical conditions related to service and aims to improve the quality of medico-scientific outcomes under the relevant Acts.

Scope and Application

The Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022) applies to veterans, current and former members of the Defence Force, and their dependents who may be eligible for compensation and medical treatment for conjunctivitis under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This instrument amends the existing Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 76 of 2020) by introducing a new factor relating to 'having a sensitising exposure to an allergen' as a contributing factor to conjunctivitis, thereby enhancing the assessment of claims and the provision of benefits. The instrument is applicable nationally within Australia, as it is determined under the authority of the Veterans' Entitlements Act 1986, which is a Commonwealth Act. The instrument does not specify any exclusions, exemptions, or thresholds for its application but instead focuses on incorporating the latest medical-scientific evidence into the criteria for assessing claims. This legislative instrument finalises an investigation initiated by the Repatriation Medical Authority and is compatible with human rights as it does not infringe upon any rights and, in fact, promotes several human rights including social security, adequate living standards, and health.

Key Provisions

The Amendment Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 90 of 2022) amends the Statement of Principles concerning conjunctivitis (Reasonable Hypothesis) (No. 76 of 2020) by inserting a new factor in subsection 9(5A) concerning 'having a sensitising exposure to an allergen' and defining 'sensitising exposure to an allergen' in Schedule 1 – Dictionary (subsection 9(5A) and Schedule 1). This amendment facilitates claimants and the relevant Commissions in assessing claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA) by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have conjunctivitis. The new factor of 'having a sensitising exposure to an allergen' must, as a minimum, exist before it can be said that a reasonable hypothesis has been raised, connecting conjunctivitis with the circumstances of eligible service rendered by a person. The Act imposes obligations on the Repatriation Medical Authority (the Authority) to determine the Statement of Principles concerning conjunctivitis, in accordance with subsections 196B(2) and (8) of the VEA (subsection 196B(2) and (8)). The Authority is required to advertise its intention to undertake an investigation in relation to having a sensitising exposure to an allergen as a factor in conjunctivitis in the Government Notices Gazette and circulate a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel, and their dependants (subsection 196B(2) and (8)). The Authority is also required to invite submissions from relevant parties, including the Repatriation Commission, the Military Rehabilitation and Compensation Commission, and any person having expertise in the field. There are no specific offences, penalties, or civil/criminal consequences for breach of this Instrument stated in the Explanatory Statement. However, the compatibility of this Legislative Instrument with human rights is considered, and it is stated that it does not derogate from any human rights and promotes a number of human rights, including the right to social security, an adequate standard of living, and the enjoyment of the highest attainable standard of physical and mental health (subsection 4). The Authority is also required to ensure that the rights of veterans, current and former Defence Force members, and other persons, such as their dependents, are exercised without discrimination of any kind (subsection 4).

Legal classification tags

Area of Law
Veterans' Law
Instrument
Amending Act
Concepts
Definitions & Interpretation
Commencement Provisions
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.